69 related articles for article (PubMed ID: 17038666)
21. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
24. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
25. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697
[TBL] [Abstract][Full Text] [Related]
26. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
27. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer.
Ke Z; Zhang X; Ma L; Wang L
Hum Pathol; 2008 Oct; 39(10):1438-45. PubMed ID: 18620728
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
[TBL] [Abstract][Full Text] [Related]
29. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
30. Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production.
Dowlati A; R'Zik S; Fillet G; Beguin Y
Br J Haematol; 1997 May; 97(2):297-9. PubMed ID: 9163591
[TBL] [Abstract][Full Text] [Related]
31. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
Juul S
Clin Perinatol; 2004 Mar; 31(1):129-42. PubMed ID: 15183662
[TBL] [Abstract][Full Text] [Related]
32. Effects of butyrate on the erythropoietin receptor of cell line IW201.
Hermine O; Dong YJ; Goldwasser E
Blood; 1994 Aug; 84(3):811-4. PubMed ID: 8043864
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptor expression abnormalities in lung cancer: important clues or major obstacles?
Minna JD; Mangelsdorf DJ
J Natl Cancer Inst; 1997 May; 89(9):602-4. PubMed ID: 9150178
[No Abstract] [Full Text] [Related]
34. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.
Uno F; Sasaki J; Nishizaki M; Carboni G; Xu K; Atkinson EN; Kondo M; Minna JD; Roth JA; Ji L
Cancer Res; 2004 May; 64(9):2969-76. PubMed ID: 15126327
[TBL] [Abstract][Full Text] [Related]
35. Understanding the presence and function of erythropoietin receptors on cancer cells.
Lai SY; Grandis JR
J Clin Oncol; 2006 Oct; 24(29):4675-6. PubMed ID: 17028292
[No Abstract] [Full Text] [Related]
36. [Expression of erythropoietin receptors in developing kidney glomerulus and glomerulonephritis].
Echigoya M
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):439-51. PubMed ID: 15373215
[No Abstract] [Full Text] [Related]
37. Emerging biological roles for erythropoietin in the nervous system.
Brines M; Cerami A
Nat Rev Neurosci; 2005 Jun; 6(6):484-94. PubMed ID: 15928718
[TBL] [Abstract][Full Text] [Related]
38. Do cancer cells express functional erythropoietin receptors?
Longmore GD
N Engl J Med; 2007 Jun; 356(24):2447. PubMed ID: 17568024
[No Abstract] [Full Text] [Related]
39. Expression of the erythropoietin receptor in human heart.
Depping R; Kawakami K; Ocker H; Wagner JM; Heringlake M; Noetzold A; Sievers HH; Wagner KF
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):877-8. PubMed ID: 16153943
[No Abstract] [Full Text] [Related]
40. [Erythropoietin receptor mutations].
Komatsu N
Rinsho Ketsueki; 2000 Jul; 41(7):549-53. PubMed ID: 11020976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
